BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 30253922)

  • 1. STEAP1 Inhibits Breast Cancer Metastasis and Is Associated With Epithelial-Mesenchymal Transition Procession.
    Xie J; Yang Y; Sun J; Jiao Z; Zhang H; Chen J
    Clin Breast Cancer; 2019 Feb; 19(1):e195-e207. PubMed ID: 30253922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STEAP2 is down-regulated in breast cancer tissue and suppresses PI3K/AKT signaling and breast cancer cell invasion in vitro and in vivo.
    Yang Q; Ji G; Li J
    Cancer Biol Ther; 2020; 21(3):278-291. PubMed ID: 31696760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six-transmembrane epithelial antigen of the prostate 1 expression promotes ovarian cancer metastasis by aiding progression of epithelial-to-mesenchymal transition.
    Jiao Z; Huang L; Sun J; Xie J; Wang T; Yin X; Zhang H; Chen J
    Histochem Cell Biol; 2020 Aug; 154(2):215-230. PubMed ID: 32382787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STEAP1 is over-expressed in breast cancer and down-regulated by 17beta-estradiol in MCF-7 cells and in the rat mammary gland.
    Maia CJ; Socorro S; Schmitt F; Santos CR
    Endocrine; 2008; 34(1-3):108-16. PubMed ID: 18958632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A research of STEAP1 regulated gastric cancer cell proliferation, migration and invasion in vitro and in vivos.
    Zhang Z; Hou WB; Zhang C; Tan YE; Zhang DD; An W; Pan SW; Wu WD; Chen QC; Xu HM
    J Cell Mol Med; 2020 Dec; 24(24):14217-14230. PubMed ID: 33128353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.
    Li G; Yao L; Zhang J; Li X; Dang S; Zeng K; Zhou Y; Gao F
    Tumour Biol; 2016 Jun; 37(6):7481-91. PubMed ID: 26678891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STEAP1 facilitates metastasis and epithelial-mesenchymal transition of lung adenocarcinoma via the JAK2/STAT3 signaling pathway.
    Huo SF; Shang WL; Yu M; Ren XP; Wen HX; Chai CY; Sun L; Hui K; Liu LH; Wei SH; Wang XX; Wang Y; Tian YX
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of OSR1 as a predictive biomarker for poor prognosis and lymph node metastasis in breast cancer.
    Li Y; Qin J; Wu J; Dai X; Xu J
    Breast Cancer Res Treat; 2020 Jul; 182(1):35-46. PubMed ID: 32424721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers of progression and invasion in short term follow up of untreated breast cancer patients.
    Rabi ZA; Todorović-Raković N; Vujasinović T; Milovanović J; Nikolić-Vukosavljević D
    Cancer Biomark; 2015; 15(6):745-54. PubMed ID: 26406416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over-Expressed Twist Associates with Markers of Epithelial Mesenchymal Transition and Predicts Poor Prognosis in Breast Cancers via ERK and Akt Activation.
    Zhang YQ; Wei XL; Liang YK; Chen WL; Zhang F; Bai JW; Qiu SQ; Du CW; Huang WH; Zhang GJ
    PLoS One; 2015; 10(8):e0135851. PubMed ID: 26295469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype.
    Habashy HO; Powe DG; Glaab E; Ball G; Spiteri I; Krasnogor N; Garibaldi JM; Rakha EA; Green AR; Caldas C; Ellis IO
    Breast Cancer Res Treat; 2011 Jul; 128(2):315-26. PubMed ID: 20697807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of lncRNA PANDAR reduces cell proliferation, cell invasion and suppresses EMT pathway in breast cancer.
    Li Y; Su X; Pan H
    Cancer Biomark; 2019; 25(2):185-192. PubMed ID: 31104011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The difference in miR-21 expression levels between invasive and non-invasive breast cancers emphasizes its role in breast cancer invasion.
    Petrović N; Mandušić V; Stanojević B; Lukić S; Todorović L; Roganović J; Dimitrijević B
    Med Oncol; 2014 Mar; 31(3):867. PubMed ID: 24488617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prognostic Role of STEAP1 Expression Determined via Immunohistochemistry Staining in Predicting Prognosis of Primary Colorectal Cancer: A Survival Analysis.
    Lee CH; Chen SL; Sung WW; Lai HW; Hsieh MJ; Yen HH; Su TC; Chiou YH; Chen CY; Lin CY; Chen ML; Chen CJ
    Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27104516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and prognostic analyses of the significance of STEAP1 and STEAP2 in lung cancer.
    Liu T; Niu X; Li Y; Xu Z; Chen J; Xu G
    World J Surg Oncol; 2022 Mar; 20(1):96. PubMed ID: 35346237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progression.
    Jørgensen CLT; Forsare C; Bendahl PO; Falck AK; Fernö M; Lövgren K; Aaltonen K; Rydén L
    Breast Cancer Res Treat; 2020 Jun; 181(2):369-381. PubMed ID: 32300922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Six-transmembrane epithelial antigen of the prostate 1 is associated with tumor invasion and migration in endometrial carcinomas.
    Sun J; Ji G; Xie J; Jiao Z; Zhang H; Chen J
    J Cell Biochem; 2019 Jul; 120(7):11172-11189. PubMed ID: 30714206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel tumor suppressor gene RhoBTB2 (DBC2): frequent loss of expression in sporadic breast cancer.
    Mao H; Qu X; Yang Y; Zuo W; Bi Y; Zhou C; Yin H; Deng B; Sun J; Zhang L
    Mol Carcinog; 2010 Mar; 49(3):283-9. PubMed ID: 19937980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Interleukin-13 Receptor Alpha 1 Expression in Tumor Cells Is Associated with Poor Prognosis in Patients with Invasive Breast Cancer.
    Park MH; Kwon HJ; Kim JR; Lee B; Lee SJ; Bae YK
    Ann Surg Oncol; 2017 Nov; 24(12):3780-3787. PubMed ID: 28634667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of angio-associated migratory cell protein (AAMP) on breast cancer cells in vitro and its clinical significance.
    Yin Y; Sanders AJ; Jiang WG
    Anticancer Res; 2013 Apr; 33(4):1499-509. PubMed ID: 23564791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.